Results 261 to 270 of about 1,078,683 (343)
Probiotic‐Based Materials as Living Therapeutics
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio +2 more
wiley +1 more source
ANTAGONISTS OF NUCLEIC ACID DERIVATIVES
Gertrude B. Elion, George H. Hitchings
openalex +1 more source
Nanostructured Protein Surfaces Inspired by Spider Silk
Harnessing recombinant spider silk technology, bioengineered spidroin variants enable the creation of functionalized nanostructured coatings with tunable affinity for specific targets, supporting a broad range of applications ‐ from antifouling surfaces and targeted drug delivery to advanced cell therapies and precision bio‐patterning via lithography ...
Martin Humenik, Thomas Scheibel
wiley +1 more source
Homology modeling of 3D structure of human chitinase-like protein CHI3L2
Iershov Anton +3 more
doaj +1 more source
Mechanistic Insights into the Stabilizing Role of Deep Eutectic Solvents for Nucleic Acids: An <i>In Silico</i> Analysis. [PDF]
Hardy DE +5 more
europepmc +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
Exploring the Subcellular Localization and Degradation of Spherical Nucleic Acids Using Fluorescence Lifetime Imaging Microscopy. [PDF]
Narum S +4 more
europepmc +1 more source
SOLUBILITY AND SEDIMENTATION STUDIES ON CERTAIN PENTOSE NUCLEIC ACIDS
James E. Bacher, Frank Worthington Allen
openalex +1 more source

